Wakefield Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Hold
8,331
0.27% 126
2025
Q4
$877K Sell
8,331
-238
-3% -$22.3K 0.24% 137
2025
Q3
$719K Hold
8,569
0.2% 144
2025
Q2
$678K Hold
8,569
0.19% 145
2025
Q1
$769K Buy
+8,569
New +$800K 0.23% 136
2023
Q1
Sell
-30,487
Closed -$3.38M 192
2022
Q4
$3.38M Sell
30,487
-501
-2% -$51.2K 1.43% 10
2022
Q3
$2.67M Sell
30,988
-370
-1% -$33K 1.23% 16
2022
Q2
$2.86M Buy
+31,358
New +$2.78M 1.23% 13
2021
Q2
Sell
-4,495
Closed -$331K 164
2021
Q1
$331K Buy
4,495
+539
+14% +$39.8K 0.13% 135
2020
Q4
$309K Buy
3,956
+61
+2% +$4.67K 0.13% 138
2020
Q3
$308K Buy
3,895
+27
+0.7% +$2.12K 0.14% 139
2020
Q2
$285K Sell
3,868
-860
-18% -$64.7K 0.14% 139
2020
Q1
$347K Buy
4,728
+1,166
+33% +$91.6K 0.19% 118
2019
Q4
$309K Buy
+3,562
New +$293K 0.13% 137

Other funds holding MRK

Wakefield Asset Management's MRK Position: Q1 2026 in Review

Wakefield Asset Management held its Merck (MRK) position steady in Q1 2026 at 8,331 shares worth $1M. The position accounts for 0.27% of the portfolio, ranked #126.

Wakefield Asset Management first reported a position in MRK in Q4 2019 and has held it in 14 quarters since. The position peaked at $3.38M in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Wakefield Asset Management held 8,331 shares of Merck worth $1M as of Q1 2026.
  • Wakefield Asset Management left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.27% of Wakefield Asset Management's portfolio in Q1 2026, its #126 holding.
  • Wakefield Asset Management first reported a position in Merck in Q4 2019 and has held it in 14 quarters since.
  • Wakefield Asset Management's Merck position peaked at $3.38M in Q4 2022.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Wakefield Asset Management's 13F filing for Q1 2026, filed 12 May 2026.